Cargando…
Systemic cancer and the FAMMM syndrome.
The FAMMM syndrome consists of the familial occurrence of cutaneous malignant melanoma and atypical nevi (dysplastic nevi), and is inherited as an autosomal dominant trait. Conflicting results have been reported on the question of whether the syndrome includes increased susceptibility to non-melanom...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971693/ https://www.ncbi.nlm.nih.gov/pubmed/2372499 |
_version_ | 1782134965256847360 |
---|---|
author | Bergman, W. Watson, P. de Jong, J. Lynch, H. T. Fusaro, R. M. |
author_facet | Bergman, W. Watson, P. de Jong, J. Lynch, H. T. Fusaro, R. M. |
author_sort | Bergman, W. |
collection | PubMed |
description | The FAMMM syndrome consists of the familial occurrence of cutaneous malignant melanoma and atypical nevi (dysplastic nevi), and is inherited as an autosomal dominant trait. Conflicting results have been reported on the question of whether the syndrome includes increased susceptibility to non-melanoma cancers. We have studied cancer of all anatomic sites and histologies in nine FAMMM families which were ascertained in a pigmented lesions clinic in the Netherlands. We evaluated two hypotheses: that the number of systemic cancers observed in the families was excessive, compared to expected incidence, based on Dutch incidence data, and that there was variation (or heterogeneity) among families in the frequency of systemic cancer. A significant excess of systemic cancer (especially digestive tract cancer) was observed. Significant heterogeneity was also found among the families; three of the nine families had marked excess in numbers of systemic cancers, and the remaining families had normal numbers of cancers among the known FAMMM gene carriers and their first degree relatives. Thus, we provide evidence of increased susceptibility to systemic cancer occurring in conjunction with the FAMMM syndrome in a subset of this resource. |
format | Text |
id | pubmed-1971693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1990 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-19716932009-09-10 Systemic cancer and the FAMMM syndrome. Bergman, W. Watson, P. de Jong, J. Lynch, H. T. Fusaro, R. M. Br J Cancer Research Article The FAMMM syndrome consists of the familial occurrence of cutaneous malignant melanoma and atypical nevi (dysplastic nevi), and is inherited as an autosomal dominant trait. Conflicting results have been reported on the question of whether the syndrome includes increased susceptibility to non-melanoma cancers. We have studied cancer of all anatomic sites and histologies in nine FAMMM families which were ascertained in a pigmented lesions clinic in the Netherlands. We evaluated two hypotheses: that the number of systemic cancers observed in the families was excessive, compared to expected incidence, based on Dutch incidence data, and that there was variation (or heterogeneity) among families in the frequency of systemic cancer. A significant excess of systemic cancer (especially digestive tract cancer) was observed. Significant heterogeneity was also found among the families; three of the nine families had marked excess in numbers of systemic cancers, and the remaining families had normal numbers of cancers among the known FAMMM gene carriers and their first degree relatives. Thus, we provide evidence of increased susceptibility to systemic cancer occurring in conjunction with the FAMMM syndrome in a subset of this resource. Nature Publishing Group 1990-06 /pmc/articles/PMC1971693/ /pubmed/2372499 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Bergman, W. Watson, P. de Jong, J. Lynch, H. T. Fusaro, R. M. Systemic cancer and the FAMMM syndrome. |
title | Systemic cancer and the FAMMM syndrome. |
title_full | Systemic cancer and the FAMMM syndrome. |
title_fullStr | Systemic cancer and the FAMMM syndrome. |
title_full_unstemmed | Systemic cancer and the FAMMM syndrome. |
title_short | Systemic cancer and the FAMMM syndrome. |
title_sort | systemic cancer and the fammm syndrome. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971693/ https://www.ncbi.nlm.nih.gov/pubmed/2372499 |
work_keys_str_mv | AT bergmanw systemiccancerandthefammmsyndrome AT watsonp systemiccancerandthefammmsyndrome AT dejongj systemiccancerandthefammmsyndrome AT lynchht systemiccancerandthefammmsyndrome AT fusarorm systemiccancerandthefammmsyndrome |